Human Papillomavirus and Coronary Artery Disease in Climacteric Women: Is There an Association?

Table 2

Association between clinical variables of participants and HPV status.

Variable	HPV positive (n=23)	HPV negative (n=29)	p	OR (95% CI)
BMI, kg/m^2
< 30	14 (60.9)	21 (72.4)	0.2865	Ref
≥ 30	9 (39.1)	8 (27.6)		0.57 (0.23–1.36)
Blood pressure, mmHg
< 130 x 85	4 (17.4)	11 (37.9)	0.002	Ref
≥ 130 x 85	19 (82.6)	18 (62.1)		4.5 (1.52 – 12.29)
Triglycerides, mg/dL
< 150	13 (56.6)	19 (65.5)	0.6767	Ref
≥ 150	10 (43.4)	10 (34.5)		0.7692 (0.33–1.75)
HDL Cholesterol, mg/dL
≥ 50	5 (21.7)	10 (34.5)	0.008	Ref
< 50	18 (78.3)	19 (65.5)		3.8 (1.41 – 10.37)
Blood glucose, mg/dL
< 100	14 (60.9)	16 (55.2)	0.8473	Ref
≥ 100	9 (39.1)	13 (44.8)		0.92 (0.43 – 1.97)
HB1AC, %
< 5,4	4 (17.4)	6 (20.7)	0.7665	Ref
≥ 5,4	19 (82.6)	23 (79.3)		1.23 (0.30-5.04)
hs-CRP, mg/dL
< 0,3	9 (39.1)	15 (51.7)	0.4042	Ref
≥ 0,3	14 (60.9)	14 (48.3)		1.55 (0.67 – 3.59)
Metabolic Syndrome
No	13 (56.6)	18 (62.1)	0.8383	Ref
Yes	10 (43.4)	11 (37.9)		0.84 (0.34 – 2.04)
CAD
No	7 (30.4)	18 (62.1)	0.0467	Ref
Yes	16 (69.6)	11 (37.9)		3.74 (1.16-11.96)

OR: odds ratio; CI: confidence interval, BMI: body mass index; Ref: reference.